Get Prestige Consumer Healthcare alerts:Read Our Latest Stock Report on PBHHedge Funds Weigh In On Prestige Consumer HealthcarePrestige Consumer Healthcare Stock Up 1.7 %A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company.
Prestige Consumer Healthcare has a 12-month low of $56.61 and a 12-month high of $75.80.
Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%.
On average, research analysts anticipate that Prestige Consumer Healthcare will post 4.43 earnings per share for the current fiscal year.
Recommended StoriesReceive News &amp; Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives $94.20 Average Target Price from Brokerages